NEWLY DIAGNOSED GLIOBLASTOMA
Clinical trials for NEWLY DIAGNOSED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a transplant drug help fight glioblastoma?
Disease control OngoingThis early-phase trial tests whether adding the drug mycophenolate mofetil (MMF) to standard radiation therapy is safe for people with glioblastoma, an aggressive brain cancer. About 68 participants with newly diagnosed or recurrent glioblastoma will receive different doses of MM…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug ST101 takes on Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug called ST101 in people with advanced solid tumors that cannot be removed by surgery or have spread. The trial includes cancers like glioblastoma, melanoma, breast, and prostate cancer. It aims to find a safe dose and see if the drug can shrin…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC